About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Purinergic Signalling
›
top-articles
Purinergic Signalling
2.5
(top 20%)
impact factor
908
(top 20%)
papers
25.5K
(top 10%)
citations
70
(top 10%)
h
-index
2.6
(top 20%)
impact factor
1.1K
all documents
27.2K
doc citations
118
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Cellular function and molecular structure of ecto-nucleotidases
Purinergic Signalling
2012
850
2
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
Purinergic Signalling
2006
795
3
Alkaline Phosphatases
Purinergic Signalling
2006
486
4
Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
Purinergic Signalling
2005
456
5
Physiological roles for ecto-5’-nucleotidase (CD73)
Purinergic Signalling
2006
443
6
ATP synthesis and storage
Purinergic Signalling
2012
340
7
P2 receptors in cardiovascular regulation and disease
Purinergic Signalling
2008
309
8
Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8
Purinergic Signalling
2005
258
9
Purinergic signalling and cancer
Purinergic Signalling
2013
258
10
Vesicular and conductive mechanisms of nucleotide release
Purinergic Signalling
2012
254
11
Purinergic signalling and immune cells
Purinergic Signalling
2014
254
12
Purines 2008 Meeting 29 June – 2 July 2008, Copenhagen, Denmark
Purinergic Signalling
2008
243
13
CD39 and control of cellular immune responses
Purinergic Signalling
2007
233
14
ATP release from non-excitable cells
Purinergic Signalling
2009
202
15
Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses
Purinergic Signalling
2013
184
16
The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
Purinergic Signalling
2018
184
17
Molecular and functional properties of P2X receptors—recent progress and persisting challenges
Purinergic Signalling
2012
181
18
Pathophysiology of astroglial purinergic signalling
Purinergic Signalling
2012
171
19
P2X ion channel receptors and inflammation
Purinergic Signalling
2016
170
20
Ecto-5’-nucleotidase: Structure function relationships
Purinergic Signalling
2006
159
21
The P2X7 receptor–pannexin connection to dye uptake and IL-1β release
Purinergic Signalling
2009
157
22
ATP release via anion channels
Purinergic Signalling
2005
154
23
Extracellular NAD and ATP: Partners in immune cell modulation
Purinergic Signalling
2007
152
24
The GDA1_CD39 superfamily: NTPDases with diverse functions
Purinergic Signalling
2011
139
25
The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson’s disease
Purinergic Signalling
2020
139
26
In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization
Purinergic Signalling
2012
137
27
Purinergic signalling in the urinary tract in health and disease
Purinergic Signalling
2014
137
28
Modulation of purinergic signaling by NPP-type ectophosphodiesterases
Purinergic Signalling
2006
130
29
P2X7 receptor: Death or life?
Purinergic Signalling
2005
126
30
P2X7: a growth-promoting receptor—implications for cancer
Purinergic Signalling
2009
124
31
A1R–A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes
Purinergic Signalling
2013
123
32
Cardiac purinergic signalling in health and disease
Purinergic Signalling
2015
115
33
Genetics of the P2X7 receptor and human disease
Purinergic Signalling
2009
114
34
P2Y12 receptors in platelets and other hematopoietic and non-hematopoietic cells
Purinergic Signalling
2012
114
35
Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors
Purinergic Signalling
2015
111
36
Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
Purinergic Signalling
2011
108
37
P2 receptors and platelet function
Purinergic Signalling
2011
108
38
Purinergic signalling in the musculoskeletal system
Purinergic Signalling
2013
104
39
Purinergic signalling and diabetes
Purinergic Signalling
2013
103
40
Roles of P2 receptors in glial cells: focus on astrocytes
Purinergic Signalling
2006
102
41
C terminus of the P2X7 receptor: treasure hunting
Purinergic Signalling
2011
102
42
Internalization and desensitization of adenosine receptors
Purinergic Signalling
2008
101
43
Development of selective agonists and antagonists of P2Y receptors
Purinergic Signalling
2009
101
44
P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways
Purinergic Signalling
2009
101
45
P2 receptor-mediated signaling in mast cell biology
Purinergic Signalling
2010
101
46
Adenosine A2A receptors in Parkinson’s disease treatment
Purinergic Signalling
2008
97
47
Purinergic receptors in the endocrine and exocrine pancreas
Purinergic Signalling
2008
92
48
LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia
Purinergic Signalling
2016
91
49
Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification
Purinergic Signalling
2006
90
50
P2Y receptors and pain transmission
Purinergic Signalling
2004
89
site/software ©
exaly
; All materials licenced under
CC by-SA
.